CT
NVS icon

Caldwell Trust’s Novartis NVS Stock Holding History

Caldwell Trust’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$353K Hold
2,310
– – 0.03% 263
2025
Q4 		$318K Sell
2,310
-618
-21% -$80.9K 0.03% 271
2025
Q3 		$375K Sell
2,928
-199
-6% -$24.3K 0.04% 250
2025
Q2 		$378K Sell
3,127
-140
-4% -$15.8K 0.04% 245
2025
Q1 		$364K Sell
3,267
-63
-2% -$6.71K 0.04% 245
2024
Q4 		$324K Hold
3,330
– – 0.03% 258
2024
Q3 		$383K Hold
3,330
– – 0.04% 245
2024
Q2 		$355K Sell
3,330
-100
-3% -$10K 0.04% 246
2024
Q1 		$332K Hold
3,430
– – 0.04% 252
2023
Q4 		$346K Sell
3,430
-325
-9% -$31.4K 0.04% 239
2023
Q3 		$382K Hold
3,755
– – 0.05% 223
2023
Q2 		$379K Hold
3,755
– – 0.05% 225
2023
Q1 		$345K Sell
3,755
-250
-6% -$21.8K 0.05% 230
2022
Q4 		$363K Sell
4,005
-1,165
-23% -$98.1K 0.05% 219
2022
Q3 		$393K Sell
5,170
-1
-0% -$83 0.06% 207
2022
Q2 		$437K Sell
5,171
-255
-5% -$22.4K 0.06% 202
2022
Q1 		$476K Sell
5,426
-127
-2% -$11K 0.06% 207
2021
Q4 		$486K Sell
5,553
-508
-8% -$42.2K 0.06% 210
2021
Q3 		$496K Sell
6,061
-131
-2% -$11.8K 0.06% 205
2021
Q2 		$565K Sell
6,192
-230
-4% -$20.5K 0.07% 179
2021
Q1 		$549K Sell
6,422
-598
-9% -$53.7K 0.08% 178
2020
Q4 		$663K Sell
7,020
-144
-2% -$12.6K 0.1% 147
2020
Q3 		$623K Sell
7,164
-220
-3% -$19.1K 0.1% 141
2020
Q2 		$645K Sell
7,384
-225
-3% -$19.4K 0.11% 143
2020
Q1 		$627K Sell
7,609
-606
-7% -$54.1K 0.12% 133
2019
Q4 		$778K Buy
+8,215
New +$737K 0.12% 141

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caldwell Trust's NVS Position: Q1 2026 in Review

Caldwell Trust held its Novartis (NVS) position steady in Q1 2026 at 2,310 shares worth $353K. The position accounts for 0.03% of the portfolio, ranked #263.

Caldwell Trust first reported a position in NVS in Q4 2019 and has held it in 26 quarters since. The position peaked at $778K in Q4 2019. 1,592 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • Caldwell Trust held 2,310 shares of Novartis worth $353K as of Q1 2026.
  • Caldwell Trust left its Novartis share count unchanged in Q1 2026.
  • Novartis made up 0.03% of Caldwell Trust's portfolio in Q1 2026, its #263 holding.
  • Caldwell Trust first reported a position in Novartis in Q4 2019 and has held it in 26 quarters since.
  • Caldwell Trust's Novartis position peaked at $778K in Q4 2019.
  • 1,592 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Caldwell Trust's 13F filing for Q1 2026, filed 22 Apr 2026.